1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 4
FEATURED COMPANIES
- Abbott
- bioMérieux
- Bio-Rad Laboratories
- QIAGEN
- Sight Diagnostics
- MORE
The growing incidence of malaria in countries has increased the need for malaria rapid diagnostic devices, which can provide rapid test results and can help in better diagnosis. The number of cases of malaria is higher in Africa and Southeast Asian countries because of poverty, the lack of healthcare infrastructure, and less knowledge about parasitic infectious diseases. The growing incidence of malaria is resulting in an increasing demand for malaria diagnostic that provide rapid results. Many countries are promoting the use of malaria rapid diagnostic products such as systems and rapid test kits to facilitate early diagnosis. Therefore, growing incidence of malaria will drive the overall market growth. The analysts have predicted that the malaria rapid diagnostics devices market will register a CAGR of over 5% by 2023.
Market Overview
Product launches
Companies are focusing on strengthening their market positions and to expand their product portfolio by offering different types of malaria rapid diagnostic products, including assays, tests, and kits. Also, many companies are receiving pre-market approval for its product which in turn will also drive the market growth.
Inaccuracy in rapid diagnostics tests
Inaccuracy and inconsistency in rapid diagnostic test results hinder the adoption of malaria rapid diagnostic devices. The adoption of rapid diagnostic products has increased as they provide rapid test results. However, inaccurate test results (false-negative and false-positive results) can lead to misdiagnosis and wrong treatment. Regulatory bodies have no specific guidelines on how to conduct the rapid diagnostic tests.
For the detailed list of factors that will drive and challenge the growth of the malaria rapid diagnostics devices market during the 2019-2023, view this report.
Competitive Landscape
The malaria rapid diagnostics devices market appears to be moderately fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Market Overview
Product launches
Companies are focusing on strengthening their market positions and to expand their product portfolio by offering different types of malaria rapid diagnostic products, including assays, tests, and kits. Also, many companies are receiving pre-market approval for its product which in turn will also drive the market growth.
Inaccuracy in rapid diagnostics tests
Inaccuracy and inconsistency in rapid diagnostic test results hinder the adoption of malaria rapid diagnostic devices. The adoption of rapid diagnostic products has increased as they provide rapid test results. However, inaccurate test results (false-negative and false-positive results) can lead to misdiagnosis and wrong treatment. Regulatory bodies have no specific guidelines on how to conduct the rapid diagnostic tests.
For the detailed list of factors that will drive and challenge the growth of the malaria rapid diagnostics devices market during the 2019-2023, view this report.
Competitive Landscape
The malaria rapid diagnostics devices market appears to be moderately fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4
FEATURED COMPANIES
- Abbott
- bioMérieux
- Bio-Rad Laboratories
- QIAGEN
- Sight Diagnostics
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
Exhibit 01: Global point of care (POC) diagnostics market
Exhibit 02: Segments of global point of care (POC) diagnostics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Consumables - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Consumables - Year-over-year growth 2019-2023 (%)
Exhibit 21: Systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Systems - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 29: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 31: Confirmed cases of malaria in few European countries 2011-2015
Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: North America - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Incidence per 1,000 people in countries 2015
Exhibit 39: Product launches
Exhibit 40: Product recalls
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Strategic business alliances
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Strategies of companies leading to market penetration
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Abbott - Vendor overview
Exhibit 50: Abbott - Business segments
Exhibit 51: Abbott - Organizational developments
Exhibit 52: Abbott - Geographic focus
Exhibit 53: Abbott - Segment focus
Exhibit 54: Abbott - Key offerings
Exhibit 55: Abbott - Key customers
Exhibit 56: bioMérieux - Vendor overview
Exhibit 57: bioMérieux - Business segments
Exhibit 58: bioMérieux - Organizational developments
Exhibit 59: bioMérieux - Geographic focus
Exhibit 60: bioMérieux - Segment focus
Exhibit 61: bioMérieux - Key offerings
Exhibit 62: bioMérieux - Key customers
Exhibit 63: Bio-Rad Laboratories - Vendor overview
Exhibit 64: Bio-Rad Laboratories - Business segments
Exhibit 65: Bio-Rad Laboratories - Organizational developments
Exhibit 66: Bio-Rad Laboratories - Geographic focus
Exhibit 67: Bio-Rad Laboratories - Segment focus
Exhibit 68: Bio-Rad Laboratories - Key offerings
Exhibit 69: Bio-Rad Laboratories - Key customers
Exhibit 70: QIAGEN - Vendor overview
Exhibit 71: QIAGEN - Product segments
Exhibit 72: QIAGEN - Geographic focus
Exhibit 73: QIAGEN - Segment focus
Exhibit 74: QIAGEN - Key offerings
Exhibit 75: QIAGEN - Key customers
Exhibit 76: Sight Diagnostics - Vendor overview
Exhibit 77: Sight Diagnostics - Organizational developments
Exhibit 78: Sight Diagnostics - Key offerings
Exhibit 79: Sight Diagnostics - Key customers
Exhibit 80: Validation techniques employed for market sizing
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segmentation by product
- Comparison by product
- Consumables - Market size and forecast 2018-2023
- Systems - Market size and forecast 2018-2023
- Market opportunity by product
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- ROW - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- North America - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Strategic alliances
- Presence of government funding and investments
- Growing demand towards non-invasive products
- Overview
- Landscape disruption
- Competitive scenario
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott
- bioMérieux
- Bio-Rad Laboratories
- QIAGEN
- Sight Diagnostics
- Research methodology
- List of abbreviations
Exhibit 01: Global point of care (POC) diagnostics market
Exhibit 02: Segments of global point of care (POC) diagnostics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Consumables - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Consumables - Year-over-year growth 2019-2023 (%)
Exhibit 21: Systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Systems - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 29: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 31: Confirmed cases of malaria in few European countries 2011-2015
Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: North America - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Incidence per 1,000 people in countries 2015
Exhibit 39: Product launches
Exhibit 40: Product recalls
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Strategic business alliances
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Strategies of companies leading to market penetration
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Abbott - Vendor overview
Exhibit 50: Abbott - Business segments
Exhibit 51: Abbott - Organizational developments
Exhibit 52: Abbott - Geographic focus
Exhibit 53: Abbott - Segment focus
Exhibit 54: Abbott - Key offerings
Exhibit 55: Abbott - Key customers
Exhibit 56: bioMérieux - Vendor overview
Exhibit 57: bioMérieux - Business segments
Exhibit 58: bioMérieux - Organizational developments
Exhibit 59: bioMérieux - Geographic focus
Exhibit 60: bioMérieux - Segment focus
Exhibit 61: bioMérieux - Key offerings
Exhibit 62: bioMérieux - Key customers
Exhibit 63: Bio-Rad Laboratories - Vendor overview
Exhibit 64: Bio-Rad Laboratories - Business segments
Exhibit 65: Bio-Rad Laboratories - Organizational developments
Exhibit 66: Bio-Rad Laboratories - Geographic focus
Exhibit 67: Bio-Rad Laboratories - Segment focus
Exhibit 68: Bio-Rad Laboratories - Key offerings
Exhibit 69: Bio-Rad Laboratories - Key customers
Exhibit 70: QIAGEN - Vendor overview
Exhibit 71: QIAGEN - Product segments
Exhibit 72: QIAGEN - Geographic focus
Exhibit 73: QIAGEN - Segment focus
Exhibit 74: QIAGEN - Key offerings
Exhibit 75: QIAGEN - Key customers
Exhibit 76: Sight Diagnostics - Vendor overview
Exhibit 77: Sight Diagnostics - Organizational developments
Exhibit 78: Sight Diagnostics - Key offerings
Exhibit 79: Sight Diagnostics - Key customers
Exhibit 80: Validation techniques employed for market sizing
Note: Product cover images may vary from those shown
3 of 4
LOADING...
4 of 4
FEATURED COMPANIES
- Abbott
- bioMérieux
- Bio-Rad Laboratories
- QIAGEN
- Sight Diagnostics
- MORE
Global Malaria Rapid Diagnostics Devices Market 2019-2023
The analyst recognizes the following companies as the key players in the global malaria rapid diagnostics devices market: Abbott, bioMérieux, Bio-Rad Laboratories, QIAGEN, Sight Diagnostics.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the presence of government funding and investments.”
According to the report, one of the major drivers for this market is the increasing awareness about the early diagnosis of malaria will increase the adoption of rapid malaria diagnostics devices and will drive the overall market growth.
Further, the report states that one of the major factors hindering the growth of this market is the challenges associated with transportation, storage, and handling of rapid diagnostics tests.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The analyst recognizes the following companies as the key players in the global malaria rapid diagnostics devices market: Abbott, bioMérieux, Bio-Rad Laboratories, QIAGEN, Sight Diagnostics.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the presence of government funding and investments.”
According to the report, one of the major drivers for this market is the increasing awareness about the early diagnosis of malaria will increase the adoption of rapid malaria diagnostics devices and will drive the overall market growth.
Further, the report states that one of the major factors hindering the growth of this market is the challenges associated with transportation, storage, and handling of rapid diagnostics tests.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
- Abbott
- bioMérieux
- Bio-Rad Laboratories
- QIAGEN
- Sight Diagnostics
Note: Product cover images may vary from those shown
